EU Pharma Strategy: Success depends on access to Generic, Biosimilar and Value Added Medicines

25 November 2020

Failure to launch: white paper explores the role of inappropriate use of IP in blocking access to generic and biosimilar medicines

5 November 2020

Statement from the President: Now or never: pragmatism & ambition needed in EU pharma strategy to deliver on Europe’s medicines manufacturing

7 October 2020

Berlin, 07 October 2020, speaking at ‘For a Healthy Europe’, […]

Am fost foarte mândru de eforturile industriei noastre de a uni și a pune interesul pacienților absolut pe primul loc în timpul acestei crize

5 October 2020

Interviu cu Adrian van den Hoven, director general Medicines for Europe  […]

Practical measures are paramount for robust medicines manufacturing

9 September 2020

Christoph Stoller and Adrian van den Hoven interviewed by PharmaBoardroom

17 July 2020

In the wake of the publication of Medicines for Europe’s Lessons […]

COVID-19 a lightning rod for major overhaul of EU pharmaceutical policy

9 July 2020

Urgent call for a structured industry-EU dialogue on reform The […]

EU Pharmaceutical Strategy Roadmap: high time to improve patient access to medicines and to apply the lessons from Covid19

4 June 2020

Letter to EU Trade Ministers. European Industry trade and supply chain needs to respond to Covid-19

10 April 2020

A statement from the President on COVID-19

8 April 2020